Meningococcal B Vaccination (4CMenB) in Infants and Toddlers - Test2 - elhamkhani - TriplyDB

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

http://www.wikidata.org/entity/Q26782285

about

Strategies to develop vaccines of pediatric interest.Fighting Neisseria meningitidis: past and current vaccination strategies.Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.

P2860

Q38819027-E1E161D3-4C9A-4D7F-85A5-D8A10CCCF7A5 Q38829564-AB7B0BD0-F9E5-4797-AC5D-99021E820672 Q54233532-DA2DF1A7-5F02-48EA-9846-213A74AB48F9

P2860

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

http://www.wikidata.org/entity/Q26782285

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@ast

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@en

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@nl

type

label

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@ast

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@en

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@nl

prefLabel

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@ast

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@en

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@nl

P1433

Q26782285-7C28E1E2-94C9-4FD7-AA9E-8F3333DBE07C

P1476

Q26782285-5B34FBB0-D789-44CD-A3DC-A16C020278B3

P2093

Q26782285-DE847375-BD1E-4F47-90F6-7F7449EA0176

P275

Q26782285-12A54E74-43CB-452F-9B05-C12D52D20AE8

P2860

Q26782285-02E072B5-B7B8-4CDA-AC56-C81736138CDA

Q26782285-0D2B7122-EB5B-48E8-825B-9FF0E21BD936

Q26782285-0E43423C-AE6F-4EC7-B9A3-1067BFAF3C57

Q26782285-14898195-FAF2-487F-A189-960611159C7F

Q26782285-15D3F064-232E-45F0-B100-A36070353CE4

Q26782285-18AA19BB-7645-4E64-81F9-79A190371BA6

Q26782285-1DF5C7F5-034A-457B-9918-C21D82667152

Q26782285-22F0359F-BEEE-4366-84EB-6846A9EBB082

Q26782285-2B0F10DA-3228-4400-B024-08F3F51A0BC9

Q26782285-30186A3D-BEA4-4643-B49F-0A664A056785

P304

Q26782285-04D95F04-B29D-4AED-B9D7-CED6D6BC3E5D

P31

Q26782285-674BAD1D-28C7-432D-978B-004A421D1FDC

Q26782285-9AE68873-13D3-4480-8CBA-CFC9C0AD3041

P356

Q26782285-48A3523B-6F9F-49C6-B2EB-30F854E3E409

P407

Q26782285-210E592D-9B8C-4B66-9DD2-FFF6C518BC9A

P478

Q26782285-B571A9E4-C720-4285-8428-43027C0DD675

P50

Q26782285-91ADD032-B4D0-453A-8105-8DA228882AE6

Q26782285-F35AE42D-3852-4CF4-91A3-C8528EE0B2C2

P5008

Q26782285-B942EA75-B606-402C-907B-376A146513B6

P577

Q26782285-764E32E2-8E20-4272-88C8-CA052A5578A5

P5875

Q26782285-FBCEDE1B-19E9-4067-A39A-B778AE6606D6

P698

Q26782285-DD22C752-E7DC-458A-AE65-4605D7934D76

P921

Q26782285-21CD9108-3B4F-4A64-A38E-889C7BDBD024

Q26782285-2BD9B114-DDF7-45C6-8129-7F169A6C7CC2

Q26782285-63FEC73C-4CF7-4346-84CB-5C352EFBECFC

Q26782285-8C5ADAA2-2B3F-4214-B822-C929A90B417C

P932

Q26782285-3CF131A5-BFAA-4FDE-84B1-065BA617C4EA

P356

P1433

Journal of Immunology Research

P1476

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

@en

P2093

Samantha Bosis

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

NadA, a novel vaccine candidate of Neisseria meningitidis

Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle?

A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements.

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.

P304

402381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/402381

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Susanna Esposito

Claudia Tagliabue

P5008

P577

2015-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281635027

http://www.w3.org/2001/XMLSchema#string

P698

26351647

http://www.w3.org/2001/XMLSchema#string

P921

preventive health services

biomedical investigative technique

meningococcal meningitis

P932

4553319

http://www.w3.org/2001/XMLSchema#string